AzTrials
AzTrials

Back PainEPCS XIr-ZjNCT05813639

EuroPainClinicsStudy XIr-Zj

A study testing Lumbar medial branch cryo ablation neurotomy, Lumbar medial branch radiofrequency ablation neurotomy and Endoscopic denervation of fazet joint in people with Back Pain, run by EPC Education s.r.o. at 1 site in Slovakia.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Determine the efficacy of lumbar medial branch neurotomy by radiofrequency and cryoablation in patients with chronic low back pain Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Back Pain
What is being tested?
Lumbar medial branch cryo ablation neurotomy, Lumbar medial branch radiofrequency ablation neurotomy and Endoscopic denervation of fazet joint
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteSlovakia
Study dates
2 Apr 2023to 1 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients aged between 20 and 80
  • positive two medial branch nerve blocks with pain relief over 80% during the first 12 hours after nerve block application
  • positive patient history of facet joint pain
  • patients with chronic low back pain for at least 6 months with back pain and leg pain (VAS >=5)
  • those who (only if a signature was obtainable), or whose legal guardian, fully understood the clinical trial details and signed the informed consent form

Who cannot join

  • patients with a history of other spinal diseases (compression fracture, spondylitis, tumor)
  • women with positive a pregnancy tests before the trial or who planned to become
  • pregnant within the following 3 years
  • other patients viewed as inappropriate by the staff
  • disagreement with participation in the study

Trial locations and contacts

1 site in 1 country.

Slovakia1 site
  • MD, PhD, FIPP Rapcan

    Bardejov, 08501

Other trials in Slovakia

About this study

Official title: EuroPainClinicsStudy XIr-Zj (Cryoablation vs Radiofrequency Ablation of Medial Nerve Branches of Dorsal Roots Crossing Z Joints)

Determine the efficacy of lumbar medial branch neurotomy by radiofrequency and cryoablation in patients with chronic low back pain

Read the detailed description

Facet joint pain encompasses a significant portion of the possible sources of pain in patients with vertebrogenic algic syndrome.A typical symptom caused by facet joint irritation of the medial branch nerve is a back pain with intermittent irregular patchy pain spreading to the legs. The cause of this pain is irritation of the medial branch of the dorsal nerve root which innervates a facet joint. Confirmation of the source of the pain involves local anaesthetic blocks of the medial nerve branches in several adjoining vertebral areas. If this test is positive, then the patient's condition is indicated for radiofrequency ablation or cryoablation of the nerve branches. Description of interventional procedures: Patients with chronic low back pain with confirmed zygapophysial joint pain after previous two medial branch nerve blocks with positive results are indicated for radiofrequency medial neurotomy or alternative cryoablation neurotomy. Navigation with probes in both cases is arranged and directed according to fluoroscopic imaging.

Conditions
Back Pain
Being tested
Lumbar medial branch cryo ablation neurotomy, Lumbar medial branch radiofrequency ablation neurotomy, Endoscopic denervation of fazet joint
Medical subject headings
Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lumbar medial branch cryo ablation neurotomyProcedure or surgery

    The procedure is based on positive lumbar Z- joint testing followed by medial branch neurotomy

  • Lumbar medial branch radiofrequency ablation neurotomyProcedure or surgery

    The procedure is based on positive lumbar Z- joint testing followed by medial branch neurotomy

  • Endoscopic denervation of fazet jointProcedure or surgery

    The procedure is based on positive lumbar Z- joint testing followed by decapsulation of the facet joint through an endoscopic approach

Study groups in NCT05813639
Study groupRoleWhat they receive
Lumbar medial branch cryoablationExperimentalLumbar medial branch cryoablation Procedure lumbar medial branch cryoablation Decreasing the electrode temperature to - 85 C for 120 seconds in two cycles. Follow-up: before the procedure, 3 months, 6 months, 12 months, and 24 months after the procedure Repeated cryoablation ablation procedures are allowed (when VAS will be =/> 4 ) Procedure/Surgery: Lumbar medial branch cryo ablation neurotomy A procedure based on positive lumbar Z- joint testing followed by medial branch neurotomy
Receives: Procedure: Lumbar medial branch cryo ablation neurotomy
Lumbar medial branch RF neurotomyExperimentalLumbar medial branch RF neurotomy Procedure lumbar medial branch RF neurotomy: Raising the temperature of the tip of the electrode to 85 C for 120 seconds. RF generator. Follow-up: before the procedure, 3 months, 6 months, 12 months, and 24 months after the procedure. Repeated cryoablation ablation procedures are allowed (when VAS will be > 4 )
Receives: Procedure: Lumbar medial branch radiofrequency ablation neurotomy
Lumbar fazet joint decapsulationExperimentalLumbar facet joint decapsulation through an endoscopic approach
Receives: Procedure: Endoscopic denervation of fazet joint

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change From Baseline EuroQoL-5 Dimension (EQ-5D) Value 36m

    EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression

    Measured: 36 months follow-up

  2. Change From Baseline EuroQoL-5 Dimension (EQ-5D) Value 12m

    EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression

    Measured: 12 months follow-up

  3. Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 12m

    Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 12m measured by VAS 10 point measurement

    Measured: 36 months follow-up

  4. Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 36m

    Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 36m measured by VAS 10 point measurement

    Measured: 36 months follow-up

  5. Oswestry Disability Index (ODI) 12m

    The ODI self-administered questionnaire measuring 0-100 scale

    Measured: 12 months follow-up

  6. Oswestry Disability Index (ODI) 36m

    The ODI self-administered questionnaire measuring 0-100 scale

    Measured: 36 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2023
  2. Study start2 Apr 2023
  3. Primary completion1 Jul 2026 (estimated)
  4. Study completion1 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospectively randomized patients with positive facet joint syndrome
Masking
Single blind
Who is masked
Care provider
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05813639
Sponsor's protocol ID
6146/2022/ODDZ-25513
Acronym
EPCS XIr-Zj
Status last verified
Jun 2026
First submitted
2 Apr 2023
Last updated
18 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: publishing results

Publications

  • Kocan L, Rapcan R, Mlaka J, Griger M, Poliak L, Lences P, Kovalicova L, Manik E, Sherdil N, Burianek M, Vaskova J. Comparative Effectiveness of Radiofrequency Ablation, Cryoablation, and Endoscopic Denervation for Lumbar Facet Pain: A Multicenter Trial. Spine (Phila Pa 1976). 2026 Jan 1;51(1):1-8. doi: 10.1097/BRS.0000000000005539. Epub 2025 Nov 4.

    PubMed 41084911

Questions about this trial

What is this clinical trial studying?

A study testing Lumbar medial branch cryo ablation neurotomy, Lumbar medial branch radiofrequency ablation neurotomy and Endoscopic denervation of fazet joint in people with Back Pain, run by EPC Education s.r.o. at 1 site in Slovakia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Slovakia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change From Baseline EuroQoL-5 Dimension (EQ-5D) Value 36m (time frame: 36 months follow-up). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05813639, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in